Carl Zeiss Meditec AG (LTS:0DHC)
€ 56.45 -1.475 (-2.55%) Market Cap: 5.13 Bil Enterprise Value: 5.24 Bil PE Ratio: 26.58 PB Ratio: 2.53 GF Score: 80/100

Q4 2023 Carl Zeiss Meditec AG Earnings Call Transcript

Dec 12, 2023 / 08:30AM GMT
Release Date Price: €93.31 (+6.34%)
Operator

Ladies and gentlemen, and welcome to the Carl Zeiss Meditec conference call. Let me now turn the floor over to your host. Sebastian, please go ahead.

Sebastian Frericks Carl Zeiss Meditec AG;Director
IR

Yeah. Good morning, ladies and gentlemen, both who joined in presence and those who joined us online. Very happy to have you here for our annual conference for the fiscal year '22, '23. I'm Sebastian, I'm the Head of Group Finance and Investor Relations. And I'm thrilled to say we have a very special lineup of speakers today.

So first, and as usually, our earnings calls are Board members of management, our President and CEO, Dr. Markus Weber. Our CFO, Justus Wehmer will take you through our financials of the past fiscal year and provide you an outlook for '23-'24. We also have here, still sitting in the back, coming up -- moving on front later on, Dr. Euan Thompson, Head of our Ophthalmology Business; Andy Chang, President of Carl Zeiss Meditec USA and the Head of the Ophthalmology Sales.

And very excited to also introduce a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot